Furthermore, genomic variability in DNM3 (coding for dynamin 3) modifies the age of onset in G2019S-LRRK2 PD patients and recently dynamin 2 has been shown to participate in the activation of mTORC1 [145,146]. This evidence concerns the gene LRRK2 and Parkinson disease.